BEAT...88...🥳...Buying Dips on offering... HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock
April 14, 2026 10:00 PM
Business Wire
Offering is being led by HeartBeam’s first commercial customer, ClearCardio™, the Company's executive leadership, board members, and existing investors
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common stock for total gross proceeds of $10 million, before deducting underwriting discounts, commissions, and offering expenses. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,875,000 shares to cover over-allotments, if any, at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about April 16, 2026, subject to customary closing conditions.
The offering is being led by HeartBeam’s first commercial customer, ClearCardio™, the Company's executive leadership, board members, existing investors, and several fundamental institutional investors.
Market Data 
Markets 
AI
